CA2236998A1 - Ribozymes specifiques de tissus ou d'arn cible - Google Patents
Ribozymes specifiques de tissus ou d'arn cibleInfo
- Publication number
- CA2236998A1 CA2236998A1 CA002236998A CA2236998A CA2236998A1 CA 2236998 A1 CA2236998 A1 CA 2236998A1 CA 002236998 A CA002236998 A CA 002236998A CA 2236998 A CA2236998 A CA 2236998A CA 2236998 A1 CA2236998 A1 CA 2236998A1
- Authority
- CA
- Canada
- Prior art keywords
- ribozymes
- specific
- target rna
- tissue
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000053642 Catalytic RNA Human genes 0.000 title abstract 10
- 108090000994 Catalytic RNA Proteins 0.000 title abstract 10
- 108091092562 ribozyme Proteins 0.000 title abstract 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/127—DNAzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/554,369 US5824519A (en) | 1995-11-08 | 1995-11-08 | Tissue-specific and target RNA-specific ribozymes |
| US08/554,369 | 1995-11-08 | ||
| PCT/US1996/018088 WO1997017433A1 (fr) | 1995-11-08 | 1996-11-08 | Ribozymes specifiques de tissus ou d'arn cible |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2236998A1 true CA2236998A1 (fr) | 1997-05-15 |
| CA2236998C CA2236998C (fr) | 2007-05-29 |
Family
ID=38149860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002236998A Expired - Fee Related CA2236998C (fr) | 1995-11-08 | 1996-11-08 | Ribozymes specifiques de tissus ou d'arn cible |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2236998C (fr) |
-
1996
- 1996-11-08 CA CA002236998A patent/CA2236998C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2236998C (fr) | 2007-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1561815A3 (fr) | Ribozymes spécifiques de tissus et d'ARN ciblé | |
| EP1248791A4 (fr) | Modulation anti-sens de l'expression de la caspase 3 | |
| WO1999014346A3 (fr) | THERAPIES GENIQUES A BASE D'ARNm SENS | |
| WO1996019568A3 (fr) | Analogues de ribozymes stabilises | |
| EP1131465A4 (fr) | Modulation antisens de l'expression de l'interleukine 15 | |
| AR240251A1 (es) | Metodo para preparar una composicion para tratamiento de infecciones virales y un metodo para sintetizar 3' azido 2', 3' dideoxiuridina destinada a la preparacion de dicha composicion. | |
| WO2003048324A3 (fr) | Modulation antisens de l'expression de la phospholipide scramblase 3 | |
| EP1248794A4 (fr) | Modulation antisens de l'expression de la proteine smad7 | |
| WO2002010378A3 (fr) | Modulation antisens de l'expression de ptp1b | |
| EP1135402A4 (fr) | Modulation antisens de l'expression d'egr-1 | |
| EP1189918A4 (fr) | Modulation antisens de l'expression d'integrine beta 3 | |
| EP1131107A4 (fr) | Modulation antisens de l'expression de kappa b kinase alpha inhibitrice | |
| EP1131332A4 (fr) | Modulation antisens de l'expression de la kappa b kinase beta inhibitrice | |
| EP1224202A4 (fr) | Modulation antisens de l'expression de kinase liee aux integrines | |
| WO2001029175A3 (fr) | Modulation antisens de l'expression de fra-1 | |
| EP1212456A4 (fr) | Modulation antisens de l'expression de shp-2 | |
| EP1268507A4 (fr) | Modulation antisens de l'expression du facteur de transcription e2f-1 | |
| WO2001083513A3 (fr) | Modulation antisens de l'inhibiteur de l'expression de la fixation 1 a l'adn | |
| EP1144690A4 (fr) | Modulation antisens de l'expression d'un inhibiteur cellulaire d'apoptose-2 | |
| WO2002050248A3 (fr) | Modulation antisens de l'expression de l'hepsine | |
| EP1250347A4 (fr) | Modulation antisens de l'expression de akt-3 | |
| WO2002064737A3 (fr) | Modulation antisens de l'expression de la sous-unite beta catalytique de proteine phosphatase 2 | |
| EP1165145A4 (fr) | Regulation antisens d'expression de mdmx | |
| CA2236998A1 (fr) | Ribozymes specifiques de tissus ou d'arn cible | |
| WO2002036810A3 (fr) | Modulation antisens de l'expression de la taline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |